Skip to content
★ Sign in to follow
PeptiDream Inc. logo

PeptiDream Inc. Stock: price and insider trades · Japan

ペプチドリーム株式会社

JP·Mcap JP¥136.2BHealth Care

No insider purchase over the last 90 days. The latest, by Unknown, was filed 05 Sept 2022.

PeptiDream Inc.: what insiders have been doing

Headquartered in Tonomachi, Japan, PeptiDream Inc. belongs to the Health Care sector and traces its origins to 2006. Filings by its managers are published through EDINET (Japan FSA). In the past year (26 October 2025 to 26 October 2026), 2 filings came from 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of PeptiDream Inc. for at least a year.

Compared with its exchange (3,205 companies, median 3 filings), a count of 2 filings is below the norm. Over the whole record (from 2021), the tally stands at 121 purchases and 89 sales.

Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.

Key facts

Headquarters: Tonomachi, Japan · Founded: 2006

Source: Wikidata (CC0).

Insider Decl.
236
Thresholds
n/a
Buy Volume
€447M
121 ops. · all time
Sell Volume
€180M
89 ops. · all time

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate PeptiDream Inc. Strong Buy (bullish), based on 6 analysts. Average price target: JP¥2,608.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,324 of 26,911 companies
25.1
score / 100
Value
20
Quality
30
FCF yld-11%
Earn yld-2.8%
EV/EBITDA·
ROE-7.1%
Gross mgn41%
Net mgn-20%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥1,060
Analyst consensus
6 analysts
Strong buy
JP¥1,100Target JP¥2,608(+146%)JP¥4,400
Income statement
RevenueJP¥18.5B
Gross profitJP¥7.5B41% margin
EBITDA-JP¥2.7B-14% margin
Net income-JP¥3.7B-18.9% margin
Valuation
P/Book2.8x
Beta0.15
Balance sheet & cash
Market capJP¥136.2B
Total debtJP¥17B
Free Cash Flow-JP¥15B
Debt / Equity32%
Profitability & ownership
ROE-7.1%
ROA-4.0%
% insiders26.6%
% institutions36.2%
Last declaration on 7 October 2026
Declarations236 total
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Z64X
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100XRDE
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100VMWZ
  • ●
    Related company / holdingExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100V6G9
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100SIAQ
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100S1BC
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100RF6V
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100RBVG
  • ●
    Large shareholderExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100QX73
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100QJFO
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100Q9EP
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100PTQN
  • ●
    Related company / holdingExecutives
    0EDINET
    ShareXTKSEDINET:S100PAK3
  • ●
    Unknown
    Large shareholderExecutives
    6EDINET
    8.9% of flowShareXTKSEDINET:S100P3ZR
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    50,400 sharesShareXTKSEDINET:S100P3ZR:T13
    Canonical exit: 25 Oct 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    24,500 sharesShareXTKSEDINET:S100P3ZR:T15
    Canonical exit: 27 Oct 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    64,000 sharesShareXTKSEDINET:S100P3ZR:T17
    Canonical exit: 31 Oct 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    74,700 sharesShareXTKSEDINET:S100P3ZR:T18
    Canonical exit: 1 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    64,000 sharesShareXTKSEDINET:S100P3ZR:T19
    Canonical exit: 2 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    60,900 sharesShareXTKSEDINET:S100P3ZR:T21
    Canonical exit: 6 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    65,000 sharesShareXTKSEDINET:S100P3ZR:T22
    Canonical exit: 7 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    183,100 sharesShareXTKSEDINET:S100P3ZR:T23
    Canonical exit: 8 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    41,000 sharesShareXTKSEDINET:S100P3ZR:T24
    Canonical exit: 10 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    25,100 sharesShareXTKSEDINET:S100P3ZR:T26
    Canonical exit: 14 Nov 2022 (T+90)
  • ▲
    Unknown
    Large shareholderExecutives
    0EDINET
    25,000 sharesShareXTKSEDINET:S100P3ZR:T27
    Canonical exit: 15 Nov 2022 (T+90)

25 of 236 declarations

About PeptiDream Inc.

Peptidream is a company focused on the development of peptides for pharmaceutical applications. It is listed on the XTKS market.